• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound

$3,500.00 – $7,000.00

Clear
SKU: KLI2101580 Categories: Diagnostics Market Research, Medical Imaging & In Vivo Testing Pages: 190
  • Description
  • Table of Contents
  • Latest reports

Description

This report analyzes the current and potential world market for medical MRI and
ultrasound systems. This report generally reviews the nature and direction of research, as
well as future markets for two key areas of imaging technology: Ultrasound and MRI.

the report includes the following as part of its market coverage:

 

  • Current Market Size and Forecast for MRI Systems
  • Market Size and Forecasts for MRI Procedures
  • Installed Base of MRI Systems

 

    • (Open, Closed, Low to Mid Field, High Field)

 

  • Estimated Cost of MRI Systems

 

    • (Open, Closed, Low Field, Mid Field, High Field)

 

  • Regional Breakdown – US, Europe, Asia, and ROW
  • Major Trends Driving Growth
  • Review of Products on the Market
  • Profiles of Key Companies.

 

 

The information presented
in Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound is the result of data gathered from company product literature and other
corporate brochures and documents, as well as information found in the scientific and
trade press. In addition, interviews were conducted with company executives, clinicians
and researchers.

Companies Profiled
This report profiles the following companies: In the MRI market: Analogic, GE Healthcare,
Hitachi Medical Systems, Philips, Fonar, Siemens and Toshiba, among others.

In the ultrasound
market: companies profiled include Aloka, Analogic, Esaote, GE Healthcare, Hitachi
Medical Systems, Philips, Shimadzu, Siemens, SonoSite, and Toshiba, among others.

MRI: Applications Drive Growth
The market for MRI continues to grow despite the recession. With its ability to image both anatomically and functionally, MRI has found its way into surgical planning and navigation as well as diffusion and perfusion imaging. It is being combined with other modalities to achieve new heights of image clarity. For instance, once considered unreliable in imaging cartilage, it is being considered for assessing chondral damage and repair. Three dimensional (3D) MRI is sensitive enough to replace arthroscopy.

MRI has been propelled by improved image quality facilitated by higher field strength magnets and the development of new techniques for evaluating specific portions of the complex structures in the brain.
More than two decades ago, when clinical MRI was in its early stages, it had serious limitations. The standard pulse sequence at that time was conventional spin echo (CSE). While a very robust method of imaging, and to this date still the gold standard for image contrast in MRI, it suffered from excessively long scan times. Many thought that MRI would never be suitable for cardiac, vascular, very high spatial resolution or true dynamic imaging. But as MRI gained clinical acceptance, the demand for the ability to image those areas that were previously deemed impossible has increased, with a strong emphasis on reducing the acquisition times. The quest for faster imaging has been the impetus for the development of new sequences, improved coil design and significant hardware advances.

This demand has led to new applications and markets for the modality.
Most of these significant hurdles have been overcome. With the advent of Gradient Echo, Fast Spin Echo and Echo Planar sequences, scan times have been reduced dramatically, making cardiac imaging possible. Over the last few of years, cardiac MRI has received new emphasis – diversifying from structural and simple qualitative functional imaging.

Now myocardial contractility and cardiac volumes may be measured with great accuracy. To further add to the cardiac imaging repertoire, intravenous gadolinium contrast agents, in conjunction with sequences designed to assess myocardial perfusion and degree of viability, are becoming commonplace. This application has significantly impacted patient management in cases of myocardial infarction in which revascularization is being considered. Where previously a full cardiac workup would have required visits to both echo cardiology and nuclear medicine, all the information can be obtained in a single visit to the MRI department. The detail and accuracy of the cardiac MRI exam is such that it is now considered the gold standard for cardiac imaging.

Ultrasound Enjoys Popularity and Ubiquity in Healthcare Practice
Ultrasound continues to be a low-cost and effective imaging technology that can help radiologists and others gather significant clinical data about patients. Ultrasound is well suited to many patients. No other imaging option gives patients a real-time look at their anatomy or openly encourages discussions with physicians about their symptoms and the evidence of disease on the monitor. Ultrasound is safe, patient-friendly and inexpensive. The adoption of this modality by hospitals and other healthcare institutions has generated new market opportunities for manufacturers of ultrasound systems and components suppliers.
Ultrasound imaging systems have become commonplace in many offices of cardiologists, obstetricians, surgeons, and urologists, among other specialists.

New applications, such as the use of ultrasound in administering emergency medicine, along with new hand-held portable systems are helping to further fuel the medical marketplace for the technology. In addition, ultrasound systems attract users simply because of their emphasis on user-friendliness, compactness and mobility.

 

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

1.1 MRI

1.2 Ultrasound

1.3 Key Challenges and Opportunitie

1.3.1 MRI

1.3.1.1 Streamlining Operations

1.3.2 Ultrasound

1.3.2.1 Optimizing Resolution

1.4 World Market Growth

1.4.1 MRI

1.4.2 Ultrasound

1.5 Methodology

 

CHAPTER TWO: OVERVIEW

2.1 Key Applications

2.1.1 MRI

2.1.1.1 Angiography

2.1.1.2 Cardiac

2.1.1.3 Black Blood MRI

2.1.1.4 Whole Body

2.1.1.5 Head

2.1.1.6 Spine

2.1.1.7 Breast

2.1.2 Ultrasound

2.1.2.1 Obstetrics and Gynecology

2.1.2.2 Breast

2.1.2.3 Abdominal

2.1.2.4 Skeletal

2.1.2.5 Prostate

 

CHAPTER THREE: INTRODUCTION

3.1 MRI

3.1.1 History and Perspective

3.1.2 Imaging Techniques

3.1.2.1 Dynamic Contrast-Enhanced MRI

3.1.2.2 Diffusion Tensor Imaging

3.1.2.3 T2*-weighted gradient-echo MRI

3.1.2.4 Functional MRI

3.1.3 Closed and Open Systems

3.1.4 Various Designs

3.1.4.1 1.5T

3.1.4.2 3T

3.1.4.3 7T

3.1.5 Competing Modalities

3.1.5.1 Computed Tomography

3.1.5.2 The X-Ray

3.1.5.3 Ultrasound

3.2 Ultrasound

3.2.1 History and Perspective

3.2.2 Basic System Components

3.2.3 Advanced Techniques

3.2.3.1 Elastography

3.2.4 Competing Modalities

3.2.4.1 Magnetic Resonance Imaging

3.2.4.2 Radiography

3.3 Imaging Biomarkers

3.3.1 Optimizing Drug Development

3.4 Key Challenges and Issues

3.4.1 MRI

3.4.1.1 Better Coil Design

3.4.1.2 Optimizing Magnets

3.4.1.3 Improving Throughput, Patient Friendliness

3.4.1.4 Costs and Reimbursement

3.4.1.4.1 Equipment Utilization Factor

3.4.1.5 Good Manufacturing Practices

3.4.2 Ultrasound

3.4.2.1 Contrast Agents

3.4.2.2 Patient Size

 

CHAPTER FOUR: RESEARCH EFFORTS

4.1 Acute Appendicitis

4.2 Stress Echocardiogram and Contrast

4.3 Ultrasound Mammography

4.4 New Magnetics

4.5 Liver Diagnoses

4.6 Magnetic Resonance Elastography

4.7 Cardiovascular MRI

4.8 MR Arthrography

 

CHAPTER FIVE: MARKETS

5.1 Market Drivers

5.2 MRI

5.2.1 Head, Neck, Brain Scannin

5.2.2 Heart-Cardio Scannin

5.2.3 Breast Scan

5.2.4 Geographic Analysis and Forecast

5.3 Ultrasound

5.3.1 Market Growth Area

5.3.2 Geographic Analysis and Forecasts

 

CHAPTER SIX: CORPORATE PROFILES

6.1 MRI

6.1.1 Advanced Imaging Research Inc.

6.1.2 American Magnetics Inc.

6.1.3 Analogic Corp.

6.1.4 B. E. Peterson Inc.

6.1.5 Biophan Technologies Inc.

6.1.6 Doty Scientific Inc.

6.1.7 Esaote SpA

6.1.8 Fonar Corp.

6.1.9 GE Healthcare

6.1.10 Hitachi Medical Systems America Inc.

6.1.11 Hologic Inc.

6.1.12 IMRIS

6.1.13 InnerVision MRI Ltd.

6.1.14 Invivo Corp.

6.1.15 MagneVu

6.1.16 Medrad Inc.

6.1.17 MetPlas

6.1.18 Millenium Technology Inc.

6.1.19 MR Instruments Inc.

6.1.20 ONI Medical Systems Inc.

6.1.21 Paramed Medical Systems Inc.

6.1.22 Philips Healthcare

6.1.23 Resonance Research Inc.

6.1.24 Siemens Healthcare

6.1.25 Time Medical

6.1.26 Toshiba America Medical Systems

6.2 Ultrasound

6.2.1 Aloka

6.2.2 American Medical Design

6.2.3 Analogic Corp.

6.2.4 Biomedicom

6.2.5 Dynamic Imaging Ltd.

6.2.6 Echoson SA

6.2.7 Elpol Sp Zoo

6.2.8 Esaote SpA

6.2.9 GE Healthcare

6.2.10 Hitachi Medical Systems America Inc.

6.2.11 LJB Development Inc.

6.2.12 Medison America Inc.

6.2.13 MySono.com

6.2.14 Paradigm Medical Industries

6.2.15 Philips Medical Systems

6.2.16 Shimadzu Corp.

6.2.17 Siemens Healthcare

6.2.18 SonoSite Inc.

6.2.19 Spectromed

6.2.20 Telemed

6.2.21 Terason Ultrasound

6.2.22 TomTec Imaging Systems GmbH

6.2.23 Toshiba America Medical Systems

6.2.24 Ultrasonix Medical Corp.

6.2.25 Verathon Inc.

6.2.26 Volcano Corp.

6.2.27 Zonare Medical Systems Inc.

 

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Exhibit 1: World Market for Medical Magnetic Resonance Imaging Systems, 2008-2012, Revenues (in billions)

Exhibit 2: World Market Summary: Medical Ultrasound Systems, 2008-2012,Revenues (in billions)

CHAPTER TWO: OVERVIEW

Exhibit 3: MRI Indications

Exhibit 4: Head MRI Indications

Exhibit 5: Applications for Medical Ultrasound

CHAPTER FIVE: MARKETS

Exhibit 6: Worldwide Medical MRI Installed Base Units, 2008

Exhibit 7: Worldwide Medical MRI System Prices Estimated Cost per Unit

Exhibit 8: MRI Market Trends

Exhibit 9: Key Players’ Percentage Share, Worldwide Medical MRI Equipment Market

Exhibit 10: Key Players’ Percentage Share – Worldwide Medical MRI Equipment Market

Exhibit 11: World Market for Medical MRI Systems, 2007-2012,Revenues (in billions)

Exhibit 12: World Market for Medical MRI Systems, 2007-2012,Revenues (in billions)

Exhibit 13: World Market for MRI Systems Used in Head, Neck and Brain Scanning, 2007-2012, Revenues (in billions)

Exhibit 14: U.S. Market for MRI Systems Used in Head, Neck and Brain Scanning, 2007-2012, Revenues (in millions)

Exhibit 15: World and US Markets for MRI Systems Used in Head, Neck and Brain Scanning, 2007-2012, Revenues (in billions)

Exhibit 16: World Market for MRI Systems Used in Heart-Cardio Scanning, 2007-2012, Revenues (in millions)

Exhibit 17: U.S. Market for MRI Systems Used in Heart-Cardio Scanning, 2007-2012, Revenues (in millions)

Exhibit 18: World and U.S. Markets for MRI Systems Used in Heart-Cardio Scanning, 2007-2012, Revenues (in millions)

Exhibit 19: World Market for MRI Systems Used in Breast Scanning, 2007-2012, Revenues (in millions)

Exhibit 20: U.S. Market for MRI Systems Used in Breast Scanning, 2007-2012Revenues (in millions)

Exhibit 21: World and U.S. Markets for MRI Systems Used in Breast Scanning, 2007-2012, Revenues (in millions)

Exhibit 22: North American Market for Medical MRI Systems, 2007-2012, Revenues (in billions)

Exhibit 23: European Market for Medical MRI Systems, 2007-2012, Revenues (in billions)

Exhibit 24: Asian-Latin American Market for Medical MRI Systems, 2007-2012, Revenues (in billions)

Exhibit 25: China-Other Emerging Markets for Medical MRI Systems, 2007-2012, Revenues (in billions)

Exhibit 26: Regional MRI Market Share, 2009

Exhibit 27: Worldwide Medical Ultrasound Installed Base Units, 2008

Exhibit 28: Leading Competitors’ Market Share of the Worldwide Medical Ultrasound Market, 2008

Exhibit 29: Key Players’ Percentage Share Worldwide Medical Ultrasound Equipment Market, 2008

Exhibit 30: World Market Geographic Segmentation for Medical Ultrasound Systems

Exhibit 31: World Market for Medical Ultrasound Systems, 2007-2012, Revenues (in billions)

Exhibit 32: U.S. Market for Medical Ultrasound Systems, 2007-2012, Revenues (in billions)

Exhibit 33: European Market for Medical Ultrasound Systems, 2007-2012, Revenues (in billions)

Exhibit 34: Asian Market for Medical Ultrasound Systems, 2007-2012,Revenues (in billions)

Exhibit 35: ROW Market for Medical Ultrasound Systems, 2007-2012, Revenues (in billions)

 

    In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028
    September 22, 2023
    The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition
    August 24, 2023
    30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)
    August 21, 2023
    At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023
    June 6, 2023

Related products

  • Placeholder image

    The U.S. Market for Interventional Radiology Products

    $3,500.00 – $7,000.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00
  • Placeholder image

    Cell-Based Diagnostics: Technology, Applications, and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    $4,995.00 – $9,990.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023
  • IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East September 15, 2023
  • Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market September 6, 2023
  • The Wide-Reaching Potential of Artificial Intelligence in Healthcare August 28, 2023
  • IVD for Pets: A $2.7 Billion Global Market July 24, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
What is Working in IVD: Successful Commercialization of New Products and Te...Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market,...
Scroll to top